GRUSF.US Grown Rogue International Inc

Healthcare Pharmaceuticals USA Stocks
0.3600 USD
Close of Nov 14, 2026
0.2700 0.5200
Market cap
USD 90.0M
P/E
-
P/B
6.23x
ROE
-57.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Apr 2026.

Is GRUSF.US undervalued?

Graham number

The Graham number of Grown Rogue International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Grown Rogue International Inc fundamental analysis

No fundamental analysis for Grown Rogue International Inc yet.

Grown Rogue International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Grown Rogue International Inc

Grown Rogue International Inc., through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States. It offers flower and flower pre-rolls, as well as flower-based products. The company also produces recreational marijuana and distributes it to dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.

Full company profile